Machine learning approaches to predict Acetylcholinesterase inhibition
Machine learning approaches to predict Acetylcholinesterase inhibition
批准号:
10378934
负责人:
SEAN EKINS
金额:
$25.64万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-12-10 至 2023-11-30
关键词:
AcetylcholineAcetylcholinesteraseAcetylcholinesterase InhibitorsAddressAdjuvantAdverse effectsAffectAlgorithmsAmphibiaAppletAreaBayesian ModelingBehavioralBindingBiologicalCaliberCardiovascular systemCell physiologyCessation of lifeCognitiveCollaborationsComputer softwareConvulsionsDataData SetDatabasesEelsEnvironmentEnvironmental PollutionEnzymesEquilibriumExposure toFingerprintFishesFoodGoalsGraphHumanKnowledgeLacrimationLibrariesLifeLiteratureLungMachine LearningMissionModelingMucous body substanceMuscarinic Acetylcholine ReceptorMuscle fasciculationNeuraxisNeuromuscular JunctionNeuronsNeurotransmittersNicotinic ReceptorsOnline SystemsOrganOrganismOrganophosphorus CompoundsPeripheralPesticidesPharmaceutical PreparationsPharmacologic SubstancePhasePoisonPoisoningProductionPubMedReceiver Operating CharacteristicsResearchRespiratory distressScientistSeizuresSignaling MoleculeSkinSourceStatus EpilepticusStructureSynapsesTestingTimeToxic effectToxicologyTrainingTremorValidationWorkbasechemical propertycholinergiccholinergic synapsecomputing resourcesdata curationdata integrationdata modelingdrug discoveryexperiencefollow-uphigh throughput screeninginhibitormachine learning modelmachine learning pipelinemodel buildingmodel developmentmultiple datasetsnerve agentprototypepublic databasesaliva secretionscaffoldscreeningsmall moleculesoftware developmenttoolwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Acetylcholine (Ach) is a neurotransmitter at neuromuscular junctions and synapses in the autonomic and central
nervous systems. It also functions as a signaling molecule in non-neuronal contexts related to cellular functions,
such as proliferation and differentiation, as well as performing organ functions, like wound healing in skin or
mucus production in lungs. Organophosphorus (OP) are one of the most common causes of poisoning
worldwide. There are nearly 3 million poisonings per year resulting in three hundred thousand deaths of these
approximately 8000 are in the USA. Because of their unique chemical properties, OPs bind to
acetylcholinesterase (AChE), rendering the enzyme incapable of hydrolyzing ACh in the cholinergic synapses
and neuromuscular junctions. Subsequent accumulation of ACh leads to overstimulation of the affected neurons
acting through muscarinic and nicotinic receptors. The peripheral effects of excess systemic ACh include
observable toxic signs (e.g., miosis, lacrimation, salivation, fasciculation, tremors and convulsions), as well as
life- threatening cardiovascular and respiratory distress. Simultaneous progression of the cholinergic crisis within
the central nervous system ultimately induces a state of unremitting seizure known as status epilepticus.
Unmitigated OP-induced SE is associated with wide- spread neuronal damage, and concomitant cognitive and
behavioral deficits. Besides the effects directly in humans, OPs can reach humans indirectly via expose to
various types of organisms that have themselves been contaminated in the environment. Some of the adverse
effects of pesticides on non-target organisms such as fish, amphibians and humans have also occurred as a
result of biomagnifications of the toxic compounds. What is missing across public “Structure Activity/toxicity
Relationship” databases are accessible machine learning models for scientists to use to extract knowledge from
the small molecule data that is accumulating. We would propose predicting AChE inhibition from structure of the
molecule alone. Our mission is therefore to make the various public datasets much more readily accessible to
machine learning modeling by providing the underlying datasets ready to model as well as apply prebuilt models
of our own. This project therefore covers automated curation, data integration and will build a research pipeline
for machine learning model development for AChE inhibition. We now propose auto-curation of public AChE
databases which use predominantly small molecule / biological activity data (such as IC50, Ki, EC50, or % inhibition
etc), sorted by target and species. We will develop software to autocurate data, build machine learning models
and identify potential molecules that inhibit AChE from human and other species in order to predict poisoning
and possible environmental contamination. We will also validate these models with literature data outside of the
training sets and understand the applicability domain of these models to other classes of molecules besides
OPs. Our ultimate goal will be to provide software and models to predict AChE inhibition which will be a
commercial product.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical development of a Nipah Virus inhibitor
-
批准号:10761349
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2023
-
负责人:SEAN EKINS
-
依托单位:
New therapeutic approaches to identifying molecules for opioid abuse treatment
-
批准号:10385998
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2022
-
负责人:SEAN EKINS
-
依托单位:
MegaTox for analyzing and visualizing data across different screening systems
-
批准号:10094026
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2020
-
负责人:SEAN EKINS
-
依托单位:
MegaTox for analyzing and visualizing data across different screening systems
-
批准号:10470050
-
项目类别:
-
资助金额:$85.5万
-
财政年份:2019
-
负责人:SEAN EKINS
-
依托单位:
MegaTox for analyzing and visualizing data across different screening systems
-
批准号:10674729
-
项目类别:
-
资助金额:$85.5万
-
财政年份:2019
-
负责人:SEAN EKINS
-
依托单位:
MegaTrans – human transporter machine learning models
-
批准号:9768844
-
项目类别:
-
资助金额:$21.07万
-
财政年份:2019
-
负责人:SEAN EKINS
-
依托单位:
MegaPredict for predicting natural product uses and their drug interactions
-
批准号:10055938
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2019
-
负责人:SEAN EKINS
-
依托单位:
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
-
批准号:10483470
-
项目类别:
-
资助金额:$149.99万
-
财政年份:2018
-
负责人:SEAN EKINS
-
依托单位:
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
-
批准号:10641950
-
项目类别:
-
资助金额:$149.99万
-
财政年份:2018
-
负责人:SEAN EKINS
-
依托单位:
Centralized assay datasets for modelling support of small drug discovery organizations
-
批准号:9751326
-
项目类别:
-
资助金额:$69.28万
-
财政年份:2017
-
负责人:SEAN EKINS
-
依托单位:
Centralized assay datasets for modelling support of small drug discovery organizations
-
批准号:10474479
-
项目类别:
-
资助金额:$85.47万
-
财政年份:2017
-
负责人:SEAN EKINS
-
依托单位:
Centralized assay datasets for modelling support of small drug discovery organizations
-
批准号:10321747
-
项目类别:
-
资助金额:$85.51万
-
财政年份:2017
-
负责人:SEAN EKINS
-
依托单位:
Centralized assay datasets for modelling support of small drug discovery organizations
-
批准号:9619615
-
项目类别:
-
资助金额:$69.42万
-
财政年份:2017
-
负责人:SEAN EKINS
-
依托单位:
Development and validation of therapy for mucopolysaccharidosis III
-
批准号:9140990
-
项目类别:
-
资助金额:$71.72万
-
财政年份:2016
-
负责人:SEAN EKINS
-
依托单位:
Development and validation of therapy for mucopolysaccharidosis III
-
批准号:9277252
-
项目类别:
-
资助金额:$77.78万
-
财政年份:2016
-
负责人:SEAN EKINS
-
依托单位:
Development and in vitro validation of therapy for mucopolysaccharidosis III
-
批准号:9020728
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2015
-
负责人:SEAN EKINS
-
依托单位:
Development and in vitro validation of therapy for mucopolysaccharidosis III
-
批准号:8764233
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2014
-
负责人:SEAN EKINS
-
依托单位:
Biocomputation across distributed private datasets to enhance drug discovery
-
批准号:8590552
-
项目类别:
-
资助金额:$46.29万
-
财政年份:2013
-
负责人:SEAN EKINS
-
依托单位:
Biocomputation across distributed private datasets to enhance drug discovery
-
批准号:8722061
-
项目类别:
-
资助金额:$56.22万
-
财政年份:2013
-
负责人:SEAN EKINS
-
依托单位:
Identification and Validation of Targets of Phenotypic High Throughput Screening
-
批准号:8590102
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2013
-
负责人:SEAN EKINS
-
依托单位:
海外基金